Kyverna Therapeutics, INC.
Biopharmaceutical company focused on developing cell therapies for autoimmune diseases.
Based in CA
AI Overview
With $50K in lobbying spend across 2 quarterly filings, Kyverna Therapeutics, INC is an active lobbying client. Their lobbying covers 1 issue area.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $50K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Kyverna Therapeutics, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to developing cell therapies for patients.
Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and multiple sclerosis.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.